Homozygous deletions of the tumor suppressor gene p16 INK4A and de®ciency of methylthioadenosine phosphorylase (MTAP), both located on chromosome 9p21, have been independently reported in non-small cell lung cancer (NSCLC). To determine the frequency of co-deletion of these two genes, we investigated 50 samples of primary NSCLC using a quantitative PCR-ELISA. All specimens were ®xed in formalin, paran embedded and stored until assayed. Histologic subtypes included 25 adenocarcinomas (50%), 21 squamous cell carcinomas (42%) and four large cell carcinomas (8%). Homozygous deletions of MTAP exon 8 could be detected in 19 of 50 NSCLC samples (38%). Adenocarcinoma (11 of 25, 44%) showed a higher deletion frequency than squamous cell carcinoma (six of 21, 29%). In contrast, homozygous p16
Homozygous deletions of the tumor suppressor gene p16 INK4A and de®ciency of methylthioadenosine phosphorylase (MTAP), both located on chromosome 9p21, have been independently reported in non-small cell lung cancer (NSCLC). To determine the frequency of co-deletion of these two genes, we investigated 50 samples of primary NSCLC using a quantitative PCR-ELISA. All specimens were ®xed in formalin, paran embedded and stored until assayed. Histologic subtypes included 25 adenocarcinomas (50%), 21 squamous cell carcinomas (42%) and four large cell carcinomas (8%). Homozygous deletions of MTAP exon 8 could be detected in 19 of 50 NSCLC samples (38%). Adenocarcinoma (11 of 25, 44%) showed a higher deletion frequency than squamous cell carcinoma (six of 21, 29%). In contrast, homozygous p16
INK4A deletions were detected in only nine of 50 (18%) samples using speci®c primers for p16 INK4A exon 1a. No dierence between the histological subtypes and p16
INK4A deletion frequency was observed. We further investigated the ten samples with MTAP deletions but intact p16
INK4A exon 1a with primers speci®c for p16
INK4A
exon 3, the exon nearest to MTAP exon 8. Interestingly, none of the ten samples had deletion of the p16 INK4A exon 3 coding region. Fine mapping analysis performed in ten samples showed a frequent breakpoint between MTAP exon 4 and exon 5. In addition, p16 protein expression could not be detected in ®ve out of six samples with intact p16 but deleted MTAP locus. These data show a high frequency of homozygous MTAP deletions in NSCLC which is associated with detectable co-deletion of p16
INK4A in only half of the cases. This result suggests the existence either of another tumor suppressor gene telomeric of p16 Human methylthioadenosine phosphorylase (MTAP) resides in the region 9p21-22, close to a heritable fragile site Carrera et al., 1986) . This site also includes the interferon a genes (Diaz et al., 1988) and the inhibitors of cyclin dependent kinases 4 and 6 (CDK4, CDK6) known as p16 INK4A (CDKN2A) and p15 INK4B (CDKN2B) (Kamb et al., 1994; Nobori et al., 1994; Okamoto et al., 1995; Herman et al., 1997) . Loss of heterozygosity (LOH) as well as hemi-and homozygous deletions of the 9p21 region have been described in a variety of primary human tumors and cell lines including acute lymphoblastic leukemia (ALL) (Batova et al., , 1997 , melanoma (Cowan et al., 1988; Fountain et al., 1992) , ovarian cancer (Bello et al., 1990) , glioma (Nobori et al., 1991; Dreyling et al., 1995; Barker et al., 1997) , head and neck cancer (van der Riet et al., 1994) , bladder cancer (Stadler et al., 1994) , chondrosarcoma (Jagasia et al., 1996) , small cell (Merlo et al., 1994; Kim et al., 1997) and non-small cell lung cancer (NSCLC) (Nobori et al., 1993; Merlo et al., 1994; Okamoto et al., 1995; Wiest et al., 1997) .
Coincident deletions of the tumor suppressor gene p16 INK4A and MTAP seem to be the consequence of close genetic linkage, whereas the importance of the deletion of each of these two genes is quite dierent. MTAP activity represents the only catabolic pathway for 5'-deoxy-5'-methylthioadenosine (MeSAdo), which is rapidly cleaved into adenine and 5-methylthioribose-1-phosphate (Pegg and Williams-Ashman, 1969) . About 90% of the cellular adenine pool that is salvaged for nucleotide synthesis is produced by this pathway (Kamatani and Carson, 1981) . On the other hand, the tumor suppressor gene p16
INK4A encodes a 16 kDa protein inhibitor of CDK4 and CDK6 (Serrano et al., 1993) . In complex with a cyclin D, these kinases phosphorylate and thereby inactivate the retinoblastoma gene product pRb (Lukas et al., 1995) . Phosphorylation of pRb enables members of the E2F transcription factor family to activate S phase genes, permitting cell-cycle progression (Lukas et al., 1995) . Based on this mechanism, p16 appears to be a key regulator of of the G 1 phase of the cell cycle, and growth control may be lost if either p16 or pRb is missing or inactivated.
Several methods have been used to determine de®ciency of the genes located on region 9p21-22 including enzymatic assay (Kamatani et al., 1982; Traweek et al., 1988) ,¯uorescence in situ hybridization , Southern (Okamoto et al., 1995; Herman et al., 1997) and Western (Nobori et al., 1993) blot analysis, and polymerase chain reaction (PCR) (Barker et al., 1997) . Interestingly, the reported frequencies for p16 INK4A homozygous deletion (18%) and MTAP enzyme de®ciency (30%) in primary nonsmall cell lung cancer dier substantially (Okamoto et al., 1995; Nobori et al., 1993) . However the meaning of the disparity is not clear since these investigations used dierent tissue specimens, and dierent methods of deletion analysis.
To resolve the problem, we investigated homozygous deletions for both p16 INK4A and MTAP in formalin®xed, paran-embedded specimens from 50 male patients with NSCLC using a recently described PCR-enzyme-linked-immunosorbent assay (PCR-ELI-SA, Table 1 ) (Barker et al., 1997; Perry et al., 1997) . Specimens for analysis were selected at random from tumor registry records. The median age of the patient population was 65 years (range 37 ± 82 years). The histological subtypes included 25 adenocarcinoma (50%), 21 squamous cell carcinoma (42%) and four large cell carcinoma (8%). Microscope slides from each paran block were examined to identify tumor-rich regions from which samples were selectively taken for DNA extraction by microdissection. By taking samples under microscopic guidance, we could assure that DNA extracted from NSCLC specimens contained 530% contaminating DNA from normal cells. Highmolecular weight DNA (usually 45 kb) could be isolated from all samples, due to the prolonged incubation time of the paran-free DNA sample with high concentrations of proteinase K (2 mg/ml). However, some of the DNA was cleaved into smaller fragments. Purity of the extracted DNA was estimated by the 260 nm/280 nm absorbance ratio, and ranged from 1.48 to 1.86.
Standard curves for MTAP, p16 INK4A exon 1a and p16
INK4A sequences from control DNA were generated for each experiment (Figure 1) . A regression line for each target sequence was calculated according to the standard curve data obtained in the ELISA from normal placenta DNA. The quotient of MTAP or p16 INK4A PCR product ELISA absorbance values (OD) divided by that of the MTAP pseudogene (cMTAP) reference gene on chromosome 3q28 was used to normalize the values. The tumor sample gene dosage ratio was calculated from the equation:
Sample MTAP gene dosage ratio sample OD MTAP asample OD ÉMTAP control OD MTAP acontrol OD ÉMTAP PCR for each tumor sample was done at least twice. Inter-assay coecient of variation for the OD values was usually 515%. Only sample OD values in the linear range of the standard curves were considered for calculation. A sample was considered to have homozygous MTAP or p16
INK4A deletion when the normalized gene dosage ratio was 50.3, based on previous reports utilizing dierential PCR to detect p16 INK4A homozygous deletion Ueki et al., 1996) . Ratios of the MTAP, p16
INK4A exon a, and p16
INK4A exon 3 PCR products to cMTAP were calculated for all samples according to these standard curves. The OD value in the ELISA and therefore the amount of ampli®ed products depended strongly on the purity of the sample DNA. However, the reference gene sequence on chromosome 3 could be ampli®ed from all samples by PCR.
We detected homozygous MTAP deletions in 19 of the 50 samples (38%) from patients with NSCLC ( Figure 2a , Table 2 ). Adenocarcinomas showed a higher frequency of homozygous deletions (11 of 25, 44%) than squamous cell carcinomas (six of 21, 29%). Two of four large cell carcinoma samples were MTAPdeleted. No correlation between homozygous deletions and the age of the patients was evident. In contrast to the results for MTAP, we found homozygous deletions Figure 1 PCR-ELISA standard curve for MTAP exon 8. Inset shows is the corresponding agarose gel analysis of the PCR products. Zero to 100 ng of DNA from paran-embedded normal placenta were ampli®ed to show the linearity of the PCR reaction and to provide a standard for comparison of ampli®ed NSCLC DNA. PCR was performed in a total of 50 ml containing normal or sample DNA, 2.0 mM MgCl 2 , 2.0 ml digoxigenin PCR mix (200 mM each of dATP, dCTP, and dGTP, 190 mM dTTP and 10 mM digoxigenin-dUTP) (Boehringer Mannheim, Indianapolis, IN, USA), 200 ng of each 5' end biotinylated primer (Table 1) , and 5 U AmpliTaq Gold DNA Polymerase (Perkin Elmer, Branchburg, NJ, USA) in the reaction buer provided by the supplier. Cycling conditions were as follows: initial denaturation at 948C for 12 min, then 29 cycles of 948C for 1 min, annealing at 598C for 1 min (648C in case of p16 INK4A exon 1a, extension at 728C for 2 min and a ®nal extension step at 728C for 7 min. Ten ml of the PCR reactions were analysed on a 2% agarose gel containing 0.4 mg/ml ethidium bromide Figure 2b . To identify the smallest deleted region in the NSCLC samples with p16
+/ MTAP7 status, we performed a ®ne mapping analysis by quantitative PCR-ELISA as described above. We could localize a frequent telomeric breakpoint within the MTAP gene between MTAP exon 4 and 5 (Figure 3) . Immunohistology for p16 were 520% in all experiments and are not shown in the ®gure. Gene dosage was determined as described in the text. Microscopically identi®able regions of tumor were shaved and placed in a sterile microcentrifuge tube containing 500 ml of sterile phosphate-buered saline (PBS), pH 7.2. After melting the paran at 708C for 10 min, the samples were immediately centrifuged at 12 000 g for 10 min at room temperature. The hardened paran ring at the surface was carefully discarded. After repeating the paran removal, DNA isolation was performed using a Qiagen Tissue Kit (Qiagen, Chatsworth, CA, USA) with the following modi®cation: samples were incubated at 378C for 96 h with further addition of 40 ml proteinase K (20 mg/ml) at 48 h. After digesting contaminating RNA with 2 mg/ml RNase A, DNA was then isolated by elution with 200 ml 10 mM Tris-HCL, pH 9.0. Purity and yield were measured using a spectrophotometer. PCR-ELISA was performed as recently described Perry et al., 1997) with slight modi®cations. Due to a very high GC content, p16
INK4A exon 1a ampli®cation was performed in a reaction mixture containing 5% dimethylsulfoxide, with annealing at 648C for 1 min. A total of 50 ng of DNA isolated from each sample was used for ampli®cation. We used 5' end biotinylated primers (Table 1) for MTAP exon 8, p16
INK4A exon 1a and p16 INK4A exon 3 to detect homozygous deletions. The recently cloned pseudogene of MTAP (CMTAP), localized to chromosome 3q28, served as a reference gene (Tran et al., 1997) . Primers listed in Table 1 were designed to amplify PCR products of similar length between 197 ± 250 bp. For each experiment, a standard curve was established for each ampli®ed sequence using DNA isolated from formalin-®xed, paran-embedded normal placenta. PCR conditions and establishment of standard curves were as described in Figure 1 . After separation of the ampli®ed PCR products from unincorporated digoxigenin-dUTP using a Qiagen PCR puri®cation kit, quanti®cation was performed as recently described (Perry et al., 1997) . Identi®cation and positional cloning of the tumor suppressor p16
established its proximity to MTAP, and con®rmed the co-deletion of these genes in several malignant cell lines (Nobori et al., 1994; Chen et al., 1996; Olopade et al., 1995) . Although MTAP de®ciency was detected in established cell lines from various kind of cancer, a de®ciency of the enzyme by protein blotting has been consistently detected only in primary gliomas (Nobori et al., 1991) , and NSCLC (Nobori et al., 1993) , tumors which were subsequently shown to exhibit homozygous deletions of p16 INK4A (Okamoto et al., 1995; Schmidt et al., 1994) . However, the reported frequency of p16
homozygous deletion in primary NSCLC has varied from 0 to 26% (Okamoto et al., 1995; Wiest et al., 1997; Shimizu and Sekiya, 1995; Marchetti et al., 1997) , with most values below the 30% incidence of MTAP de®ciency in the small NSCLC series. In the present study, we detected homozygous deletion of MTAP in 19 of 50 samples (38%). In contrast, homozygous p16
INK4A deletion was found in only nine of the 50 samples (18%) when sought using primer pairs speci®c for exon 1 and the 5' part of exon 3 (including the coding sequence).
There are several possible explanations why disparate frequencies of p16 INK4A deletion and MTAP de®ciency have been reported. The incidence of p16 INK4A deletion may vary depending on the tumor stage at the time of excision (Okamoto et al., 1995) , or on the smoking history of the patients. Homozygous p16 deletions were detected by dierent techniques, using probes of varying proximity or speci®city. Failure to detect homozygous gene deletion in tumors by Southern blot or by PCR may be due to the admixture of normal DNA from adjacent tissue or in®ltrating cells. In contrast, the ELISA measurement of PCR products obtained during the linear ampli®cation range allows a sensitive and reproducible discrimination of MTAP or p16
INK4A gene dosage compared to reference gene. The reliability of the PCR-ELISA has been recently established (Perry et al., 1997; Barker et al., 1997) . Assays yielding normalized ratios of MTAP : cMTAP or of p16
: cMTAP consistent with homozygous deletion were repeated at least twice (including DNA extraction steps), with little interassay variation. Thus it is unlikely that technical diculties account for the disparity between MTAP and p16 INK4A homozygous deletion in a subset of NSCLC samples as shown in Figure 2a . In addition, a high correlation between PCR-ELISA for p16 INK4A and immunohistochemistry as well as¯uorescence in situ hybridization (FISH) (Perry et al., 1997) has been shown. However, PCR-ELISA seems to be more precise since the DNA probes used for FISH analysis Five mm sections were made from each paran-block. After deparanization and hydration, samples were incubated in H 2 O 2 for 30 min to quench endogenous peroxidase activity. Slides were pretreated by heating at 1208C for 10 min in a 10 mM sodium citrate buer (pH 6.0). After incubation for 1 h at RT with a polyclonal mouse-anti human p16 INK4A antibody (1 : 100, Pharmingen, San Diego, CA USA), slides were washed twice with PBS and then exposed to a secondary, peroxidase-labeled rabbit anti-mouse antibody for 30 min at RT. Visualization was performed by diaminobenzidine reaction (Sigma, St Louis, MO USA). Slides were counterstained with Mayer's hematoxylin. Incubation with the secondary antibody alone served as a negative control. A tumor was considered to be negative for p16 INK4A expression when surrounding or in®ltrating cells stained but the tumor did not Figure 3 Mapping of 10 primary NSCLC tumor samples in the region between p16
INK4A and MTAP using gene-speci®c primers and primers for sequence tagged sites (underlined numbers on the top, described in detail in Nobori et al., 1996) . Fifty ng of total DNA were ampli®ed in each PCR reaction as described in Figure  2 . Black circles (*) represent wild type; open circles (*) indicate a homozygous deletion are usually very long (450 kb), and therefore are not suitable to detect small deletions. Our ®nding that 18% of primary NSCLC tumors have homozygous deletion of p16
INK4A is consistent with studies based on apparent retention of heterozygosity (from contaminating normal DNA) within a region of LOH, (Wiest et al., 1997) , and thus con®rms homozygous deletion as a frequent mechanism of p16 INK4A inactivation in the pathogenesis or progression of NSCLC.
Frequent homozygous deletions of p16 INK4A have also been detected in primary samples from patients with ALL (Ogawa et al., 1994; Takeuchi et al., 1995) , glioma (Barker et al., 1997; Walker et al., 1995; Schmidt et al., 1994) , pituitary tumors (Woloschak et al., 1996) , sporadic melanoma (Reed et al., 1995; Singh et al., 1996) , and head and neck squamous cell carcinoma (Reed et al., 1996) . The incidence of p16 INK4A deletion is particularly high in glioma (31 ± 64%) and in the T-cell subset of ALL (39 ± 75%) Ohnishi et al., 1995; Cayuela et al., 1996) . In contrast, p16
INK4A mutations are more common than deletions in carcinomas of the pancreas (Caldas et al., 1994) , esophagus (Mori et al., 1994) and biliary tract (Yoshida et al., 1995) . Recently, hypermethylation of CpG islands in the 5' region of p16
has been implicated as a mechanism of transcriptional suppression in various types of cancer (Batova et al., 1997; Reed et al., 1996; Merlo et al., 1995; Costello et al., 1996) .
Co-deletion of MTAP has been documented in about half of T-ALL samples with p16
INK4A deletion , and preliminary results show a similar co-deletion frequency in glioma (Schmid et al., unpublished observation). It was therefore surprising to ®nd that the frequency of MTAP homozygous deletion exceeded that of p16 INK4A in primary NSCLC samples, if the latter is indeed the primary deletion target on chromosome 9p21 during malignant transformation or progression, and there is no direct evidence that MTAP de®ciency triggers malignant transformation.
The 9p21 deletion aecting MTAP in some NSCLC may target regulatory sequences in the 3'-UTR of p16
INK4A that were not be detected by PCR amplifications we performed. Among various cancers, the absence of p16 expression by immunohistochemistry or protein blot is far more common than gene deletion as determined using exonic probes Woloschak et al., 1996; Reed et al., 1996) . In one large NSCLC series, aberrant nuclear staining for p16 was found in 51% of paran-embedded tumors (Kratzke et al., 1996) . In the present study, we could demonstrate the absence of p16 INK4A protein expression in ®ve out of six tumors that had no deletion in the p16 INK4A gene locus. The mechanism most often implicated for decreased expression of p16 INK4A in primary tumors is hypermethylation of CpG islands in the promotor regions (Herman et al., 1997; . Alternatively, the eciency of gene expression may involve cis-acting determinants in the 3'-UTR that bind regulatory proteins or that in¯uence mRNA polyadenylation (Standart and Jackson, 1994) . The 3'-UTRs of interleukin-1b and of the CDK inhibitor p21 WAF1/CIP1 not only encode AU-rich elements known to foster mRNA instability, but also contain sequences that bind regulatory molecules capable of markedly aecting expression (Li et al., 1996; Rishi et al., 1997 INK4A has been suggested by microsatellite analyses in sporadic melanoma and small cell lung cancer (Kim et al., 1997; Singh et al., 1996) . Recently, Waber et al. (1997) have provided strong evidence for the existence of this alternate tumor suppressor gene on 9p21-22 in head and neck cancer. The discovery of p16
INK4A alternative exon 1b, 20 kb centromeric of exon 1a , raises the possibility that another p16 INK4A exon lies in the 100 kb region between exon 3 and MTAP. p16
INK4A exon 1b together with p16 INK4A exon 2 encode a new protein, named p19
ARF that binds to MDM2 and is therefore capable of regulating the cell cycle (Pomerantz et al., 1998; Zhang et al., 1998) . Thus, it is likely that further complexity remains to be discovered in the genes and protein interactions of the p15/p16/p19 ARF tumor suppressor gene family.
Because MTAP activity is critical for the salvage of the adenine base during the synthesis of polyamines, homozygous deletion of MTAP may have important therapeutic implications. In vitro, cells with normal MTAP activity, but not MTAP-de®cient cells, are protected from the toxicity of purine synthesis inhibitors if methylthioadenosine or other substrate analogues are added as a source of adenine for salvage Nobori et al., 1993; Kamatani et al., 1981; Kubota et al., 1983; Hori et al., 1996) . Indeed, some MTAP-de®cient cells are intrinsically more sensitive than MTAP-positive cells to methotrexate (Chen et al., 1996) , or to the de novo adenylate synthesis inhibitor L-alanosine tested in culture against NSCLC tumors in immunode®cient mice . Thus, the sensitive PCR-ELISA detection of MTAP homozygous deletions we describe not only provides a con®rmatory marker assay for some p16
deletions, but also forms a basis for developing of novel tumor-speci®c chemotherapeutic strategies.
In the primary lung tumors studied here, the most commonly deleted segment in the 9p21 region mapped to the approximately 100 kb fragment telomeric of p16 NK4A and centromeric of MTAP. It will be important to determine if the deleted fragment contains genetic elements that regulate p16 INK4A expression in the lung. As opposed to p16
, MTAP is a gene that is expressed at substantial levels in all normal human tissues, irrespective of their state of dierentiation or proliferation. The lack of MTAP protein in cell lines, as detected by immunoblotting, correlates completely with homozygous deletion of the MTAP gene . Immunohistochemical techniques to detect MTAP negative cells in cytological specimens may become a useful approach in the diagnosis of NSCLC.
